Overall rank by patents
#49,233
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Novostia Sa
USPTO PatentsView assignee record - 5 granted patents across 1 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
5
Total patents granted
1
CPC technology areas
20.6
Avg claims per patent
+300%
5-year filing velocity
The verdict
Novostia holds 5 US patents across 1 technology areas, rank #49,233 of 50,000 tracked assignees.
- #49,233
- of 50,000 US assignees by volume
- Top 31%
- by Innovation Score (42.1/100)
- 20.6
- avg claims per patent
- +300%
- filing velocity, last 5 yrs
Portfolio overview
Novostia Sa has been granted 5 US utility patents between 2019 and 2025, placing Novostia Sa at rank #49,233 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.6 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Novostia Sa is one of the more focused assignees in the PatentsView dataset. By volume, Novostia sits between Novitech, Inc. (5 patents, rank #49,229) and Nugeneration Technologies, Llc (5 patents, rank #49,237) - the closest US assignees by grant volume. The composite Innovation Score of 42.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 1 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Novostia Sa's 20.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Novostia Sa against peers pursuing similar technology classes.
Who files at Novostia's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Novitech
Novitech, Inc.
5 patents
- Novium Taiwan
Novium Taiwan Inc.
5 patents
- Novoloop
Novoloop, Inc.
5 patents
- Novonate
Novonate, Inc.
5 patents
- Nsgene A/S
NsGene A/S
5 patents
- Nucare
NuCare, Inc.
5 patents
- Nucoat
NuCoat, Inc.
5 patents
- Nugeneration
NuGeneration Technologies, LLC
5 patents
- Novostia ◀
Novostia SA
5 patents
What this shows Novostia holds 5 patents at rank #49,233, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Novostia
By rank, the assignees closest to #49,233 in granted patent volume.
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in Novostia's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
Novostia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 20.0% |
| 2023 | 3 | 60.0% |
| 2025 | 1 | 20.0% |
Which technologies does Novostia Sa patent most?
Top 1 of 1 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Accelerating
Frequently Asked Questions
How many patents does Novostia Sa hold?
Novostia Sa holds 5 US granted patents filed between 2019 and 2025, spanning 1 technology areas.
What is Novostia Sa's Innovation Score?
Novostia Sa has an Innovation Score of 42.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Novostia Sa focus on?
Novostia Sa's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 5 patents. The company has filed patents in 1 CPC subclasses total.
Is Novostia Sa's patent filing rate increasing or decreasing?
Novostia Sa's recent filing velocity is +300% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Novostia Sa's patents?
Novostia Sa's patents average 20.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Novostia Sa patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Novostia's 5 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Novostia ranks #49,233 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.